Skip to content

The Effect of Capsule of bee propolis on Primary Dysmenorrhea of students

The Effect of Capsule of bee propolis on Primary Dysmenorrhea of students in Hamadan University of Medical Sciences

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180707040370N2
Enrollment
80
Registered
2018-08-21
Start date
2018-08-23
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhoea. Pain and other conditions associated with female genital organs and menstrual cycle

Interventions

Intervention 1: Intervention group: The bee propolis is receiving 500 mg capsules of bee propolis daily for 2 months. Intervention 2: Control group: The placebo is receiving 500 mg capsules of starch

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 23 Years

Inclusion criteria

Inclusion criteria: Be single Regular mensturation no record of major psychological diseases Not having chronic diseases or genital tract Insensitive to herbal medicine Not performing professional exercise and exposure to stressor in the last 6 months Non-specific treatment to relieve symptoms of dysmenorrhea over the past 3 months having of regular menstrual cycles and pain score more than 3 on the visual analog scale (VAS)

Exclusion criteria

Exclusion criteria: Use of birth control pills and herbal medicines; As well as painkillers and other relaxation techniques or acupressure to relieve dysmenorrhea; Having of renal; hepatic; respiratory; and blood diseases

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: before intervention, immediately after interventionand and one month after intervention. Method of measurement: Based on the Visual Analuoge Scale pain intensity.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEnsiyeh Jenabi

Hamedan University of Medical Sciences

en.jenabi@yahoo.com+98 81 3838 0496

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026